AstraZeneca delivers promising new treatment, one of the fastest-developed biologics in oncology, to address the high unmet need for third-line treatment. Enhertu (trastuzumab deruxtecan) has been...
A better understanding of the novel protein’s role in promoting breast cancer cell migration and survival presents a potential therapeutic strategy against this disease. The nuclear envelope is...
A HER2-targeted antibody-drug conjugate, fam-trastuzumab deruxtecan-nxki (Enhertu), showed signs of clinical activity in multiple non-breast/non-gastric cancer types, according to results from a...
This article talks about the different types of breast cancer present in women and treatment options available. by Dr Tan Sing Huang Breast cancer is the most frequent cancer among women, and the...
